Log In
BCIQ
Print this Print this
 

albaconazole (formerly UR-9825)

  Manage Alerts
Collapse Summary General Information
Company Palau Pharma S.A.
DescriptionBroad spectrum oral antifungal
Molecular Target 14 alpha-sterol demethylase
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationFungal infection
Indication DetailsTreat onchomycosis
Regulatory Designation
PartnerAllergan plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/12/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today